Cancer

Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative

-  The first tri-party executive roundtable was held in London to strengthen synergies for Seegene's vision of creating 'a world…

1 year ago

CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

1 year ago

Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance

Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving…

1 year ago

EDETEK Launches CONFORM™ – ONCO+, a Therapeutic Area-Specific Accelerator for the CONFORM™ Platform

Unveiling AI-Driven Accelerators to Enhance Clinical Trial Efficiency and Precision PRINCETON, N.J., Oct. 23, 2024 /PRNewswire/ -- EDETEK Inc., a…

1 year ago

ACR Poker and Its Players Raise $20,000 for the United Breast Cancer Foundation

SAN JOSE, Costa Rica, Oct. 23, 2024 /PRNewswire/ -- In support of Breast Cancer Awareness Month, ACR Poker hosted its third…

1 year ago

MEDSIR takes part in the Nexus Conference to address the challenges and opportunities of geographic diversity in clinical trials

The conference, held in New Jersey, addresses critical aspects of clinical trials in the biopharmaceutical industry in the United States.Rui…

1 year ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

Investigator initiated trial seeks to validate safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying…

1 year ago

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –SAN…

1 year ago

Creative Innovation & Investment Shine On Day Two of Global Health Exhibition in Riyadh

World class exhibitors showcase opportunities and challenges posed by frontier-pushing digital and practical health technologies, set to revolutionize patient care…

1 year ago

Complete Blood Count Test with At-Home Sample Collection is Available for Direct-to-Patient Biopharma Programs through ixlayer’s ixEngage

ixEngage removes barriers to care by accelerating pre-treatment and routine CBC tests used for hundreds of conditions, including asthma, heart…

1 year ago